Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data

SIMPLE SUMMARY: Targeting angiogenesis, the formation of new blood vessels, is an integral part of many cancer treatments, including colorectal cancer. The overall clinical benefit is well documented but modest. It has been an ongoing task for the last decade to isolate patient and tumor characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Torben Frøstrup, Qvortrup, Camilla, Pfeiffer, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957514/
https://www.ncbi.nlm.nih.gov/pubmed/33804554
http://dx.doi.org/10.3390/cancers13051031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957514/
https://www.ncbi.nlm.nih.gov/pubmed/33804554
http://dx.doi.org/10.3390/cancers13051031

Ejemplares similares